Clinical Trial

L-Carnitine Protective Effect in Nephrotoxicity

Study acronym: LC
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to assess the possible reno-protective effect of L-carnitine against cisplatin-induced nephrotoxicity in patients receiving cisplatin-based chemotherapy. The main question it aims to answer is: Does L-carnitine have the ability to protect the kidney against cisplatin-induced nephrotoxicity?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-06.
Status change: Not Yet Recruiting → Recruiting 2025-08-09
Trial Details
NCT Number NCT07108777
Lead Sponsor Tanta University
Conditions Nephrotoxicity
Enrollment 46 participants
Start Date 2025-08-10
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-12